Sanofi Ventures Secures $625M Boost, Expanding Assets to $1.4B

The fund will remain focused on Sanofi's key areas of immunology, rare diseases, neurology, and vaccines, backing earlier-stage innovation and emerging...

September 25, 2025 | Thursday | News
Ritedose Invests $17M to Expand Analytical Chemistry and Microbiology Labs

Expanded microbiology lab and analytical chemistry capabilities position Ritedose for accelerated growth. $17+ million investment fuels innovation and...

September 25, 2025 | Thursday | News
Angelini Pharma and South Korea’s Sovargen Sign Global Option Agreement for First-in-Class Brain Health Therapy SVG105

Angelini Pharma, part of the privately owned Angelini Industries, and Sovargen, a South-Korean biotechnology company, announced today that they signed an...

September 23, 2025 | Tuesday | News
Kensana Health Partners With GEM Global Yield on $120 Million Facility to Advance AI-Driven Plant-Based Medicines

Kensana Health Inc. announced it has entered into a share subscription facility of up to $120 million with GEM Global Yield LLC SCS ("GEM"), a Luxembourg...

September 22, 2025 | Monday | News
Crown Bioscience Expands US Footprint with New State-of-the-Art Model Development Center in Kannapolis, North Carolina

Crown Bioscience, a global contract research organization (CRO) headquartered in the United States and part of JSR Life Sciences and Japan-based JSR Corp...

September 18, 2025 | Thursday | News
NurExone’s U.S. Subsidiary Exo-Top Plans First Commercial Exosome Production Facility in Indianapolis

  NurExone Biologic Inc., a biopharmaceutical innovator in exosome-based regenerative therapies, is pleased to announce that its U.S. subsidiary, Exo...

September 17, 2025 | Wednesday | News
Monte Rosa Therapeutics and Novartis Expand Collaboration with New $120M Upfront Deal to Develop Novel Immunology Degraders

Novartis receives an exclusive license to an undisclosed discovery target Novartis also receives options to license two programs from Monte Rosa’s...

September 16, 2025 | Tuesday | News
Cascade Bio Secures $6M to Power Cell-Free Biomanufacturing Revolution

Cascade Bio, an industrial biotech company enabling enzyme-based processes, has secured $6M to accelerate the shift from petrochemicals to biomanufacturi...

September 10, 2025 | Wednesday | News
Enzene Inaugurates First U.S. Biomanufacturing Facility with Governor Phil Murphy in New Jersey

  Governor Phil Murphy officially inaugurated the state-of-the-art biomanufacturing facility of Enzene, a leading global continuously innovative deve...

September 10, 2025 | Wednesday | News
Samsung Biologics Secures Landmark W1.8 Trillion Manufacturing Agreement with US Partner

  Samsung Biologics, South Korea’s preeminent contract development and manufacturing organisation (CDMO), has entered into a momentous W1.8 tri...

September 10, 2025 | Wednesday | News
IFF Expands LMR Naturals Site in Grasse with €10 Million Investment to Drive Next-Generation Natural Ingredient Innovation

-IFF (NYSE: IFF), a global leader in flavors, fragrances, food ingredients and biosciences,  inaugurated its expanded LMR Naturals site in Grasse fo...

September 09, 2025 | Tuesday | News
Biocodex Leads €55M Series B with €11M Strategic Investment in MRM Health to Advance Microbiome-Based Therapeutics

Biocodex, a French family-owned pharmaceutical pioneer in microbiota research for over 70 years, announces a strategic equity investment of €11 mill...

September 05, 2025 | Friday | News
Gilead Breaks Ground on $32 Billion U.S. Innovation Commitment with New Technical Development Center in Foster City

Gilead Sciences celebrates the groundbreaking of its new Pharmaceutical Development and Manufacturing (PDM) Technical Development Center (NTDC) at the co...

September 04, 2025 | Thursday | News
Amgen to Invest $600 Million in New Science and Innovation Center at U.S. Headquarters

Research and Development Infrastructure Investment Expected to Create Hundreds of U.S. Jobs   Amgen  announced plans to invest more than ...

September 04, 2025 | Thursday | News

Survey Box

Poll of the Week

Which area of biopharmaceutical research excites you the most?

× Please select an option to participate in the poll.
Processing...
× You have successfully cast your vote.
 {{ optionDetail.option }}  {{ optionDetail.percentage }}%
 {{ optionDetail.percentage }}% Complete
More polls
Stay Connected

Sign up to our free newsletter and get the latest news sent direct to your inbox

© 2025 Biopharma Boardroom. All Rights Reserved.

Show

Forgot your password?

Show

Show

Lost your password? Please enter your email address. You will receive a link to create a new password.

Back to log-in

Close